By stratifying SLE patients by disease activity groups according to the Mex-SLEDAI score, patients with severe disease activity showed the lowest PTPN22 and IL10 mRNA levels (p < 0.05), while those with the inactive or mild-moderate disease had similar or higher expression levels compared with CS (Figure 2B). This evidence concerns the gene PTPN22 and systemic lupus erythematosus.